Compare the effect of duloxetine and nortriptyline on diabetics pai
Phase 2
Completed
- Conditions
- Diabetic Polyneuropathy.Diabetic Polyneuropathy
- Registration Number
- IRCT2016031927107N1
- Lead Sponsor
- Vice chancellor for research, Ahvaz Jundishapour University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 122
Inclusion Criteria
Age greater than 18 years; diabetes type one or two; 24-hour average pain score greater than 40 millimeter; Michigan neuropathy screening instrument scores by at least 3; and electrophysiological findings indicate neuropathy
Exclusion criteria:
Mood disorder; drug and alcohol abuse; history of epilepsy; pregnant women; peripheral vessels disease; and history of diabetes less than a year
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain. Timepoint: Every week for six weeks. Method of measurement: visual Analogue Scale Questionnaire.
- Secondary Outcome Measures
Name Time Method Drugs side effects. Timepoint: Every week for six weeks. Method of measurement: Questionnaire.